New combo inhaler may tame asthma inflammation better than standard rescue puffers
NCT ID NCT06563102
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 4 trial tested whether a combination inhaler (AIRSUPRA, containing albuterol and budesonide) works better than albuterol alone for adults with mild asthma. Over 12 weeks, researchers measured airway inflammation, daily symptoms, and how often participants needed rescue medication. The study enrolled 101 adults and compared the two treatments head-to-head.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Albuterol/budesonide (AIRSUPRA) inhaler
- What this could lead to
- If successful, this could show that a combination inhaler reduces airway inflammation and symptom flare-ups better than albuterol alone for people with mild asthma.
- What could go wrong
- This is a small, completed Phase 4 study with only 101 participants. Results may not apply to everyone with mild asthma, and the benefits over standard albuterol may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Phoenix, Arizona, 85040, United States
-
Research Site
Tucson, Arizona, 85715, United States
-
Research Site
Lancaster, California, 93534, United States
-
Research Site
San Diego, California, 92123, United States
-
Research Site
Cape Coral, Florida, 33990, United States
-
Research Site
Lake Worth, Florida, 33462, United States
-
Research Site
Columbus, Georgia, 31904, United States
-
Research Site
Boise, Idaho, 83706, United States
-
Research Site
Plainfield, Indiana, 46168, United States
-
Research Site
St Louis, Missouri, 63141, United States
-
Research Site
Riverdale, New Jersey, 07457, United States
-
Research Site
Oklahoma City, Oklahoma, 73120, United States
-
Research Site
North Charleston, South Carolina, 29420, United States
-
Research Site
El Paso, Texas, 79903, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
Waco, Texas, 76712, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.